John P. Sfakianos, MD, discusses the challenges of managing recurrent LG-IR-NMIBC and the role of chemoablation.
Beyond TURBT: Evolving Strategies in LG-IR-NMIBC
Advertisement
Advertisement
Trending on Urology Times
1
AI-generated profiles impersonate female urologists to market ED products online
2
First commercial procedures performed with Zenflow Spring for BPH
3
TRT, GLP-1s, and peptides: How to counsel patients stacking longevity therapies
4
Dabogratinib shows early activity in FGFR3-altered LG-IR-NMIBC
5